Head: Solyanik Galina Ivanivna. Development of target cancer therapy based on the combined use of energy metabjlism inhibitors of malignant cells. (popup.stage: ). R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology. № 0219U001621

Updated: 2026-10-28